ICMR's new device can diagnose tuberculosis for just ₹35
The Indian Council of Medical Research's (ICMR) regional center in Dibrugarh, Assam, has developed an innovative and cost-effective tuberculosis (TB) testing device. This breakthrough system, named 'A CRISPR case-based TB detection system,' can identify the disease using a patient's sputum at a minimal cost of just ₹35. The device is lightweight and portable, making it highly accessible for widespread use.
New device outperforms traditional testing methods
The new TB detection system significantly outperforms traditional diagnostic techniques, which often rely on culture and microscopy. These conventional methods can take up to 42 days to confirm a negative TB result, and may require sophisticated equipment. In contrast, the CRISPR-based system can test over 1,500 samples in a single run within approximately 2.5 hours, according to ICMR.
ICMR seeks partners for commercialization of TB detection system
ICMR has issued an Expression of Interest (EoI) inviting eligible organizations and manufacturers to undertake the 'Transfer of Technology' for commercializing the 'A CRISPR case-based TB detection system.' The ICMR-RMRCNE institute will offer expert guidance and technical support throughout all phases of production. This collaboration aims to expedite the development and commercialization process, making this innovative technology widely available.
